Mike Shapiro, DO, MD, director of the Center for Prevention of Cardiovascular Disease at Wake Forest University, discusses the current guidelines for computed tomography (CT) calcium scoring as a screening test to assess heart attack risk.

The company has now raised $248M in total to help develop, commercialize and market its FDA-cleared technology. 

Ancora Heart received the FDA’s breakthrough device designation for its AccuCinch Ventricular Restoration System, a new minimally invasive transcatheter device designed for the treatment of heart failure.

The FFRangio System, which uses AI to obtain fractional flow reserve (FFR) measurements from routine X-rays, is at the center of this new partnership

Charles Davidson, MD, clinical chief of cardiology and medical director of the Bluhm Cardiovascular Institute, Northwestern University, explains what hospitals need to consider when starting a new structural heart program. 

American Society of Nuclear Cardiology (ASNC) delegates to the American Medical Association (AMA) House of Delegates 2022 meeting Stephen Bloom, MD, and Nishant Shah, MD, explain a new AMA policy asking Congress to revise its clinician decision support mandate. 

The American Medical Association Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe.

A new study reveals the damage caused to cardiovascular programs by the COVID-19 pandemic will continue to accrue unless mitigation strategies are implemented quickly. The review found a number of people dying are at home from heart conditions.